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Abstract
Background: Defects in protein folding are recognized as the root of many neurodegenerative disorders. In the
endoplasmic reticulum (ER), secretory proteins are subjected to a stringent quality control process to eliminate misfolded
proteins by the ER-associated degradation (ERAD) pathway. A novel ERAD component Usa1 was recently identified.
However, the specific role of Usa1 in ERAD remains obscure.
Methodology/Principal Findings: Here, we demonstrate that Usa1 is important for substrate ubiquitylation. Furthermore,
we defined key cis-elements of Usa1 essential for its degradation function. Interestingly, a putative proteasome-binding
motif is dispensable for the functioning of Usa1 in ERAD. We identify two separate cytosolic domains critical for Usa1 activity
in ERAD, one of which is involved in binding to the Ub-protein ligase Hrd1/Hrd3. Usa1 may have another novel role in
substrate ubiquitylation that is separate from the Hrd1 association.
Conclusions/Significance: We conclude that Usa1 has two important roles in ERAD substrate ubiquitylation.
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Introduction
The majority of selective proteolysis in eukaryotes is handled by
the proteasome [1]. Substrates of the proteasome are often
covalently modified by the ubiquitin (Ub) molecule, an abundant
76-residue protein [2,3]. Ub is activated and transferred to the
substrate via several enzymes including a Ub-activating enzyme
(E1), a Ub-conjugating enzyme (E2), and a Ub-protein ligase (E3).
The rate-limiting step is likely the recognition and ubiquitylation
of the substrate by the E3 enzyme. The ubiquitylated substrate is
then degraded by proteasome. Defects in the Ub/proteasome
system can lead to cancers and neurodegenerative diseases [4].
The Ub/proteasome pathway is a part of the protein quality
control system responsible for the destruction of misfolded
polypeptides [5,6]. Nearly one third of cellular proteins enter the
endoplasmic reticulum (ER) on their way to various cellular
destinations. The folding state of secretory proteins is actively
monitored in the ER. Immature proteins are retained to fold
properly by ER chaperones. To prevent toxicity by the accumu-
lation of aberrant proteins, terminally misfolded proteins are
disposed of via a process termed ER-associated protein degradation
(ERAD) [5,7]. More specifically, these malfolded proteins are
returned to the cytosol and recognized by a Ub-protein ligase (E3),
which decorates misfolded proteins with Ub molecules that mark
the substrate for proteasome-mediated proteolysis [4]. Failure of
ERAD can lead to protein aggregation and cell death.
Multiple ERAD pathways are employed to eliminate aberrant
proteins [6,8]. Recent findings suggest that at least two
checkpoints are employed to sort ERAD substrates into different
degradation pathways based on the location of the misfolded
domain (e.g. membrane, lumen, or cytosol) and the topology of the
protein [9,10,11]. ERAD substrates with lesions exposed in the
cytosol, termed ERAD-C, are selected for degradation by the
Doa10 (E3) pathway. ERAD substrates with lesions in either ER
membrane (ERAD-M) or ER lumen (ERAD-L) are ubiquitylated
by an E3 complex composed of Hrd1 (a RING finger containing
protein) and Hrd3. Interestingly, ERAD-L requires two additional
proteins resided in the ER membrane, Usa1 and Der1 [10,11].
While Der1 is proposed to be involved in the substrate retro-
translocation since it has four transmembrane domains, the
specific role of Usa1 in ERAD is unknown.
In the cytosol, the ATPase Cdc48 in complex with two Ub-
binding proteins Ufd1 and Npl4 recognizes Ub chains and uses its
chaperone activity to extract ubiquitylated proteins out of the ER
[6,8]. How the ubiquitylated ERAD substrates are transferred to
the proteasome is not clear. Some, but not all ERAD substrates
require Ub receptors Rad23 and/or Rpn10 [6,8]. Since Usa1
contains a putative proteasome binding Ub-like motif (UBL)
[10,12,13], we considered the possibility that Usa1 may have a
role in bringing the proteasome close to the ER membrane and
thereby shuttling substrates to the proteasome. We show herein
that the UBL motif is largely dispensable for the functioning of
Usa1 in ERAD-L substrate degradation. We demonstrate that
Usa1 is specifically involved in the ERAD substrate ubiquitylation
step. Our deletion analysis uncovers two domains essential for
Usa1 function, one of which binds the Hrd1-Hrd3 E3 complex.
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7604Our data reveal that the function of Usa1 requires its association
with the Hrd1-Hrd3 E3, and further suggest that Usa1 may have
another undefined role in substrate ubiquitylation.
Results
Usa1 regulates ERAD-L substrate ubiquitylation
To determine the execution point of Usa1, we compared the
ubiquitylation pattern of misfolded CPY*, a well-defined ERAD-L
substrate, in wild-type and usa1D cells [9,10,11]. To this end, we
co-transformed the plasmid expressing Flag-tagged CPY* and the
plasmid bearing HA-tagged Ub to these cells. Ubiquitylated CPY*
species were seen in wild-type cells expressing both CPY* and HA-
Ub, but not in control cells lacking either CPY* or HA-Ub
(Figure 1A). Ubiquitylated CPY* bands were significantly reduced
in usa1D cells (Figure 1A), suggesting that Usa1 facilitates substrate
ubiquitylation.
Usa1 was shown to bind the Hrd1-Hrd3 E3 complex [10].
Although both Hrd1 and Hrd3 are inserted into the ER
membrane, their topology and functional assignments are different
[6,7]. Whereas most of Hrd3 sequences are in the ER lumen,
majority of Hrd1 sequences are on the cytosolic side. In
combination with two luminal proteins Yos9 and Kar2, Hrd3
recognizes misfolded substrates and targets them for ubiquitylation
[11]. Hrd1, a RING finger domain protein, assembles Ub-chains
onto the substrates in the cytosol. To further delineate the
interaction between Usa1 and Hrd1/Hrd3, we examined these
interactions in the presence or absence of one of the subunits.
Usa1 binds Hrd3 (Figure 1B). In the absence of Hrd1, the
interaction of Usa1-Hrd3 remained unaltered (Figure 1B). The
Usa1-Hrd1 interaction was also maintained in the absence of
Hrd3 albeit at slightly reduced level (Figure 1C). Note that Hrd1
level is known to be reduced in hrd3D cells [14,15]. Combined,
these results suggest that Usa1 interacts with Hrd1 and Hrd3
separately in vivo.
The UBL motif is not essential for Usa1 function
The majority of Usa1 sequences is projected on the cytosolic
side [10]. Besides its membrane-localization domains, the only
recognizable element in Usa1 is the UBL motif, which can bind
various components of the Ub/proteasome pathway including the
proteasome and a Ub chain elongatoion factor Ufd2 [13,16].
Unlike Rad23, another UBL-containing protein, Usa1 was not
found in association with the proteasome or Ufd2 (Figure 2A, B).
To determine the importance of this putative UBL element, we
deleted the region encompassing the UBL motif (amino acids 250–
350; UBLD also termed as d2D in Figures 3 and 4) at the genomic
USA1 locus. To evaluate the effect of the UBL deletion on Usa1
function, we examined the stability of two soluble ERAD-L
substrates, misfolded CPY* and ricin A chain (RTA), in usa1
mutant cells. Consistent with previous reports, CPY* is markedly
stabilized in usa1 null mutant (Figure 2C, D) [10]. Surprisingly,
deletion of the UBL domain does not significantly alter the
degradation of CPY* or RTA (Figure 2C, 3C), suggesting that the
UBL motif is not crucial for the functioning of Usa1 in proteolysis.
Two N-terminal domains are essential for Usa1 function
in ERAD-L
To understand how Usa1 facilitates substrate ubiquitylation, we
sought to identify critical sequence elements in Usa1 through
mutational analysis. We deleted the C-terminal cytosolic segment
(amino acids 595–838), the other two non-UBL regions of the N-
terminal Usa1 (amino acids 31–240, 351–525) separately
(Figure 3A) at the genomic locus of USA1. We found that CPY*
degradation was markedly impaired in mutants lacking one of the
N-terminal domains (Figure 3B), indicating that these two
segments are essential for Usa1 function. In contrast, the C-
terminal cytosolic tail, which accounts for nearly one third of the
protein, was not required for CPY* degradation (Figure 3B) and
was not further analyzed. Similarly, the turn-over of another
ERAD-L substrate RTA [17] is compromised by deletions of the
N-terminal, non-UBL domains (Figure 3C).
Mutations in Usa1 do not affect its membrane
localization and protein stability
Next, we examined whether the loss of function caused by these
deletions was due to the change of Usa1 localization and/or
stability. To facilitate the detection of Usa1 protein, Usa1 and its
Figure 1. Usa1 is required for efficient substrate ubiquitylation. (A) Usa1 is involved in CPY* ubiquitylation. CPY* was immunoprecipitated
from wild-type or usa1D, hrd1D cells expressing HA-tagged Ub and analyzed by immunoblotting with anti-HA antibody. The proteasome inhibitor
MG132 was added to trap CPY*. Ubiquitylated CPY* are shown on the upper panel. The bottom panel shows the levels of CPY* in these cells.
Molecular weight (kDa) is indicated on the left. (B) Co-immunoprecipitation analysis of interactions between Hrd3 and Usa1. The plasmid expressing
Flag-tagged Usa1 was transformed into wild type or hrd1D strains expressing Hrd3 tagged with HA epitope at its genomic locus. Proteins were
extracted from the indicated cells and immunoprecipitated with Flag-beads. Immunoprecipitates were separated on SDS-PAGE, and later probed
with anti-HA antibody (top panel). The amounts of Usa1 and Hrd3 in cell extracts were determined and shown in lower panels. (C) Usa1 binds Hrd1 in
the absence of Hrd3. Co-immunoprecipitation analysis of interactions between Usa1 and HA-tagged Hrd1 in wild-type or hrd3D cells was conducted
as described in (B). Note that Hrd1 expression is reduced in hrd3D strains as previously reported [14,15].
doi:10.1371/journal.pone.0007604.g001
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expressing Usa1 derivatives were divided into total, soluble, and
membrane fractions. Whereas the soluble Rad23 protein parti-
tioned into supernatant portion, Usa1 mainly resides in the
membrane fraction (Figure 3D). None of the N-terminal deletions
affected the localization of Usa1 to the membrane (Figure 3D).
Small amount of Usa1 (less than 5%) was also detected in the
soluble fractions. Whether this is due to insufficient fractionation
or related to its role in pre-mRNA splicing remains further
investigation [18]. Then, we also carried out pulse-chase assays to
measure the stabilities of Usa1 and its derivatives. Wild-type and
mutant Usa1 are stable proteins (Figure 3E and data not shown).
Defective Usa1-E3 binding affects substrate
ubiquitylation
To examine the specific defects caused by these deletions, we
examined the ubiquitylation pattern in usa1 mutants. As expected,
CPY* ubiquitylation was compromised in cells lacking USA1 or
HRD1 (Figure 4A). We found reduced ubiquitylation of CPY* in
two non-UBL deletion mutants (Figure 4A), suggesting that these
two domains are required for substrate ubiquitylation. Interest-
ingly, CPY* ubiquitylation is consistently more severely reduced in
d3D mutant than in usa1 null. Although the underlying
mechanism is not known, one possible explanation is that d3D
deletion may exert a dominant negative effect since, unlike usa1
null mutant, it still has other functional domains such as the first
N-terminal region and membrane anchoring domain. We suspect
that these two mutations may affect the association between Usa1
and other ERAD-L ubiquitylation components. First, we deter-
mined the interaction between Usa1 derivatives and Hrd1 by co-
immunoprecipitations. Interestingly, deletion of the middle
portion (i.e. d3D) abolished the binding between Usa1 and Hrd1
(Figure 4B) and also reduced the Usa1-Hrd3 interaction
(Figure 4D), suggesting that the interaction between Usa1 and
the Hrd1-Hrd3 E3 complex is important for ERAD. The N-
terminal fragment (amino acids 1–525) binds efficiently to Hrd1 in
the absence of transmembrane domain (Figure 4C and data not
shown). We also examined the binding between Usa1 and Der1.
To this end, we employed Der1-TAP, which does not support
ERAD but, nevertheless, associates with the other components of
the Hrd1-complex [10]. None of the mutations affects the Usa1-
Der1 interaction (Figure 4E). Usa1 is also known to interact with
the chaperone complex Cdc48-Ufd1-Npl4 [10], which recognize
and extract ubiquitylated proteins out of the ER membrane
[19,20,21]. Since CPY* ubiquitylation is unaltered in cdc48 mutant
[19,20], the Usa1-Cdc48 association is likely indirect and not
relevant for the functioning of Usa1 in CPY* ubiquitylation. Since
the d1D mutant retained the bindings to Hrd1, Hrd3 and Der1,
the results also suggest that the extreme N-terminal domain of
Usa1 plays a different, but undefined essential function in
ERAD-L ubiquitylation.
Discussion
Since the discovery of ERAD over a decade ago, the
physiological significance of ERAD has been increasingly
appreciated owing to its emerging, prominent role in human
diseases [4,6]. However, many important questions remain: For
example, how are substrates selected for degradation? How are
substrates retro-tranlocated across the ER membrane? How are
substrates ubiquitylated? How are ubiquitylated substrates trans-
ferred to the proteasome? Studies in yeast have led the way in
uncovering critical mechanistic attributes and the physiologic
functions of ERAD. Many key players in ERAD were first
identified in yeast, and nearly all of them have human
counterparts [8,11]. Assigning each ERAD factor to the specific
events mentioned above presents the first step to unravel this
highly coordinated choreography of ERAD.
Figure 2. The UBL domain of Usa1 is not critical for ERAD. (A) Usa1 fails to interact with the proteasome. The plasmid expressing Flag-tagged
Usa1 or Rad23 was transformed into wild type cells. To detect the association with the proteasome, the immunoprecipitates were resolved by SDS-
PAGE and probed with an antibody against Rpt5, a proteasome subunit (top panel). The amounts of Rpt5, Usa1 or Rad23 in extracts are shown in
lower panels. (B) Usa1 does not bind Ufd2. Proteins were extracted from cells expressing myc-tagged Ufd2 and Flag-Usa1 or Flag-Rad23. The
indicated immunoprecipitation and immunoblotting were carried out as described in (A). (C) UBL domain of Usa1 is not essential for CPY*
degradation. Pulse chase analysis of Flag-tagged CPY* was carried out in isogenic yeast strains BY4741 (wild-type), usa1D, YHR157 (USA1
DUBL). Yeast
cells were pulse labeled with
35S for 10 min, then cold Met/Cys mix was added to start the chase. We took samples at 20 min intervals and processed
them for immunoprecipitation with Flag-beads, followed by SDS-PAGE and autoradiography. (D) Quantitation of the data in C. The amount of
proteins was determined by phosphor-imager analysis.
doi:10.1371/journal.pone.0007604.g002
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involvement of Usa1 in ERAD-L ubiquitylation. Currently, it is
unknown whether Usa1 regulates substrate ubiquitylation directly
or indirectly. Given the membrane barrier, ERAD-L ubiquityla-
tion is likely much more complicated than typical ubiquitylation
carried out by a normal E2–E3 pair. Besides Ubc6 E2 and Hrd1
E3, other proteins (e.g. Cue1, Hsp70 chaperones) have also been
implicated in ERAD substrate ubiquitylation [22,23]. Identifica-
tion of these ubiquitylation regulators would facilitate in vitro
reconstitution of ERAD ubiquitylation.
Given its ER membrane localization and mainly cytosolic
topology [10], Usa1 has the potential to play multiple key roles in
the ERAD pathway. Interestingly, the putative UBL motif and the
C-terminal tail are not essential for ERAD-L substrate degrada-
tion (Figure 2, 3). Usa1 bridges Der1 and Hrd1 [10], which in turn
could ensure the coupling of retrotranslocation and ubiquitylation.
Our results also suggest that likely Usa1 has another function in
ERAD in addition to its associations with Der1, Hrd1 and Hrd3
since the d1D mutant with largely intact bindings to Der1 and
Hrd1/Hrd3 is defective for CPY* ubiquitylation (Figure 4). The
Figure 3. Two N-terminal fragments of Usa1 are important for ERAD. (A) Domain structure of wild-type Usa1 and various deletion mutants
constructed. Two short transmembrane domains (amino acids 537–583) anchor Usa1 to the ER membrane, but most of Usa1 sequences are in the
cytosol [10]. Grey box represents the UBL domain and black boxes indicate two transmembrane domains of Usa1. The deleted portions are shown as
solid lines. The deleted region in d2D is the same as UBLD in Figure 2. Deletion strains and plasmids of Usa1 were constructed as described in
Experimental procedures. (B) Deletions of two N-terminal segments in Usa1 impair the degradation of CPY*. Pulse chase analysis of CPY* in wild-type
and various USA1 mutant strains was performed as described in Figure 2C. The amount of CPY* left (%) is indicated under each lane. (C) Compromised
degradationofglycosylatedRTAin USA1 deletionmutants. Pulsechaseanalysis ofRTA was doneaspreviouslydescribed[17].(D)Usa1 deletionmutants
maintain the ER membrane localization. Yeast cells expressing Flag-tagged Usa1 derivatives were labeled with
35S. Protein extracts were separated into
total, membrane andsoluble fractions andsubsequently immunoprecipitated with Flag-beads. Rad23 was used as a positive control for soluble fraction.
(E) Pulse chase analysis of Usa1 wild type and its derivatives. The stabilities of Flag-tagged Usa1 alleles were determined as described in Figure 2C.
doi:10.1371/journal.pone.0007604.g003
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but may bring other cytosolic factors required for substrate
ubiquitylation close to Hrd1 [6,7]. Our results suggest that Usa1
also works with the Hrd1–Hrd3 E3 complex to facilitate substrate
ubiquitylation (Figure 4). How might Usa1 assist Hrd1 in attaching
ubiquitins onto misfolded proteins? In the presence of E1 and E2,
Hrd1 alone is sufficient to catalyze self-ubiquitylation in vitro,
indicating that Hrd1 has the Ub-protein ligase activity [24]. Usa1
is likely not essential for turning on the enzymatic activity of Hrd1,
but may still stimulate Hrd1 activity. It remains a possibility that
Usa1 could be involved in substrate retro-translocation. Our data
provides new insights regarding the mechanism governing ERAD
substrate ubiquitylation and lays the foundation for uncovering the
more detailed events in the ERAD pathway.
The human homologue of Usa1 is thought to be Herp since
Herp partially restores the ERAD-L pathway in usa1D yeast cells
[10]. Herp is induced upon ER stress and important for cell
survival under stress [25,26]. The precise function of Herp
remains elusive. Like Usa1, Herp also interacts with the
mammalian Hrd1–Hrd3 complex and is required for the
degradation of ERAD substrates (e.g., CD3-delta, connexin 43)
[26,27,28]. Interestingly, the only sequence similarity between
Usa1 and Herp is the UBL motif [10,25], which is essential for
Herp-mediated connexin 43 degradation [26] but not for Usa1-
mediated CPY* or RTA turnover (Figure 2C, 3C). Whereas Herp
is an unstable protein subjected to proteasome-mediated proteol-
ysis [26], Usa1 is quite stable (Figure 3E and data not shown).
Given our findings here, it remains to be seen whether Herp and
Usa1 perform a similar role in ERAD.
In summary, both two N-terminal, non-UBL domains are
important for the function of Usa1 in substrate ubiquitylation. Our
results lay the foundation to further uncover the detailed events
involved in ERAD ubiquitylation.
Materials and Methods
Yeast Strains and Plasmids
Cultures were grown in rich (YPD) or synthetic media
containing standard ingredients and 2% glucose (SD medium),
or 2% raffinose (SR medium), or 2% galactose (SG medium), or
2% raffinose + 2% galactose (SRG medium). Wild-type strain
BY4741 and isogenic mutant strains usa1D, hrd1D, hrd3D, der1D
and Der1-TAP were obtained from Open Biosystems (Huntsville,
AL). Yeast strains YHR161 (USA1
D31–240 in BY4741 background;
Figure 4. Effects of Usa1 deletions on substrate ubiquitylation and protein-protein interactions. (A) Ubiquitylation pattern of CPY* in
usa1 mutants. Flag-tagged CPY* was precipitated from wild-type or mutant cells with anti-Flag antibody and analyzed by immunoblotting with anti-
Ub antibody. Molecular weight (kDa) is indicated on the left. The amount of ubiquitylated and unmodified CPY* were determined by phosphor-
imager analysis. The ratio of unmodified CPY* in wild type to those in each mutant was applied to normalize the ubiquitylated CPY*. For example, the
amounts of unmodified and ubiquitylated CPY in hrd1D cells are 94% and 35% of those in wild-type cells, respectively. After the normalization,
ubiquitylated CPY* in hrd1D cells is 37% of that in wild-type cells. The relative amount of ubiquitylated CPY* is indicated under each lane. (B) The
effects of Usa1 mutations on the interaction with Hrd1. The bindings between the indicated Usa1 derivatives and HA-tagged Hrd1 were detected by
co-immunoprecipitations as described in Figure 1C. (C) The N-terminal fragment of Usa1 binds to Hrd1 without the membrane anchoring domain.
Various indicated Usa1 alleles were transformed to yeast cells bearing Hrd1 tagged with HA epitope at its genomic locus. Co-immunoprecipitations
were performed as described above. The positions of two Usa1 fragments are marked by asterisks. A cross-reacting band is present right below the
Usa1
1–525 fragment. (D) The interaction between Hrd3 and Usa1 derivatives. The bindings between the Usa1 mutants and HA-tagged Hrd3 were
detected by co-immunoprecipitations as described in Figure 1B. (E) The effects of Usa1 mutations on Der1-binding. The plasmids bearing Usa1
derivatives were transformed to yeast strain expressing Der1 modified at its C-terminus with a Tandem Affinity Purification (TAP) tag [10]. The binding
between Usa1 and Der1 was analyzed by coimmunoprecipitation (top panel). The amounts of Usa1 and Der1 in the extracts are shown in the lower
panels.
doi:10.1371/journal.pone.0007604.g004
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D250–350 ; UBL domain
deletion also called d2D), YHR163 (USA1
D351–525; d3 region
deletion), YHR165 (USA1
D595–838; d4 region deletion) were
generated by replacing the indicated stretch with URA3-Myc
cassette in BY4741, then URA3 was removed by homologous
recombination to leave 3 copies of myc tag in place of deleted
Usa1 sequences [29]. The deletions were confirmed by PCR and
DNA sequencing. Strains YTX140 (wild type), YTX297 (HRD1-
3xHA), YRG020 (6xHA-HRD3), YTX485 (HRD1-3xHA, hrd3D),
and YRG130 (6xHA-HRD3, hrd1D) are generous gifts from T.
Sommer [30]. The tagged alleles of Hrd1, Hrd3, and Der1 have
been shown to be functional in various protein-protein interactions
and protein stability assays [30].
Flag tagged misfolded CPY* was generated in the pRS416Gal1
vector as previously described [31]. To construct the plasmid
containing Flag-tagged full length Usa1 or various deletions, USA1
gene was amplified by PCR from wild type or USA1 deletion
strains and incorporated into pRS416Gal1 vector containing Flag
epitope at C-terminus. Flag-tagged RTA was previously described
[17].
Pulse-chase analysis
Pulse-chase analysis was done as described previously [17].
Yeast cells carrying plasmids that express Flag-tagged CPY*, or
RTA, or Usa1 derivatives from the PGAL1 promoter were grown at
30uCt oa nO D 600 of ,1 in galactose-containing medium. Cells
were labeled for 10 min with 0.16 mCi of
35S-Express (Perkin
Elmer), followed by the chase with 4 mM methionine and 2 mM
cysteine. Samples were taken at the indicated time points and
processed for immunoprecipitation with Flag beads (Sigma-
Aldrich), followed by SDS-PAGE and autoradiography.
Co-immunoprecipitation/immunoblotting assay
Detection of protein-protein interaction by immunoprecipita-
tion was done as described [16,17]. Briefly, yeast cells were grown
in the SRG medium to an OD600 of ,1, followed by preparation
of extracts, immunoprecipitation with the beads coated with
indicated antibody, SDS-8% PAGE, and immunoblotting,
separately, with various antibodies.
Detection of ubiquitylated CPY*
Analysis of CPY* ubiquitylation was carried out as described
previously [32]. Briefly, CPY* was immunoprecipitated from yeast
extracts treated with MG132 and the immunoprecipitates were
resolved by SDS-PAGE, and immunoblotted with the antibody
recognizing ubiquitin (Biomol).
Membrane localization of Usa1 and its derivatives
Soluble and membrane fractions of yeast cells expressing either
wild-type or mutant Usa1 were prepared by centrifugation [33].
Briefly, cells expressing Flag tagged Usa1 or Rad23 were labeled
for 1 hour with 0.1 mCi of
35S-Express (Perkin Elmer), and lysed
by glass beads. Cell debris was removed by centrifugation at
4,000 rpm for 5 minutes. Soluble proteins were separated from
membrane fraction by centrifugation at 14,000 rpm for 10
minutes. Total extract, soluble and membrane fractions were
subjected to immunoprecipitation with Flag beads, followed by
SDS-8% PAGE, and autoradiography.
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